Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
75.5M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
6.82M
-
Shares change
-
+228K
-
Total reported value, excl. options
-
$4.69M
-
Value change
-
+$179K
-
Number of buys
-
6
-
Number of sells
-
-13
-
Price
-
$0.69
Significant Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) as of Q1 2022
36 filings reported holding CLRB - Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q1 2022.
Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.82M shares
of 75.5M outstanding shares and own 9.03% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (1.84M shares), VANGUARD GROUP INC (1.75M shares), BlackRock Inc. (713K shares), Worth Venture Partners, LLC (458K shares), GEODE CAPITAL MANAGEMENT, LLC (442K shares), Maven Securities LTD (400K shares), ACT CAPITAL MANAGEMENT, LLC (218K shares), STATE STREET CORP (150K shares), FRANKLIN RESOURCES INC (142K shares), and RENAISSANCE TECHNOLOGIES LLC (127K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.